| (a) If a performer participated in DSRIP during the
initial demonstration period or DY6, its total valuation per demonstration
year (DY) for DY7 and DY8 is equal to its total valuation for DY6
with the following exceptions:
(1) If HHSC determined that a DSRIP project was ineligible
to continue in DY6, the performer affected by such a determination
may use the funds associated with the DSRIP project beginning in DY7.
(2) If a performer withdrew a DSRIP project between
June 30, 2014, and June 30, 2016, the performer may use the funds
associated with the DSRIP project beginning in DY7.
(3) If a performer participated in DSRIP during the
initial demonstration period but not during DY6 and has a total valuation
per DY for DY7-8 less than $250,000, the performer may request in
the RHP plan update to increase its total valuation to up to $250,000
per DY for DY7-8.
(b) If a performer did not participate in DSRIP during
the initial demonstration period or DY6, but begins participating
in DSRIP in DY7 in accordance with §354.1721 of this division
(relating to Remaining Funds for Demonstration Years (DYs) 7-8), its
RHP determines its valuation in accordance with §354.1721.
(c) A performer's valuation must comport with the following
funding distribution for DY7 and DY8:
Attached Graphic
(d) If a performer's RHP meets its minimum private
hospital valuation per DY for DY7-8 as described in Figure: 1 TAC §354.1707(d)(2),
the performer may allocate its DY7 and DY8 valuations as follows:
(1) 55 percent of its DY7 valuation and 75 percent
of its DY8 valuation to Category C - Measure Bundles and Measures;
and
(2) 15 percent of its DY7 valuation and 15 percent
of its DY8 valuation to Category D - Statewide Reporting Measure Bundle.
Attached Graphic
|
| Source Note: The provisions of this §354.1707 adopted to be effective December 1, 2017, 42 TexReg 6609; amended to be effective April 26, 2018, 43 TexReg 2393; amended to be effective November 12, 2019, 44 TexReg 6854 |
